August 22nd 2025
Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.
Drospirenone-Containing Contraceptives Increase Risk of Thrombotic Events
November 5th 2012Compared with older low-dose combined hormonal contraceptives (CHCs), drospirenone-containing contraceptives are associated with a higher risk of thrombotic events, according to the results of a new FDA-funded study.
Read More
Controlling Pain During Tubal Sterilization Using Hysteroscopy
October 12th 2012According to the findings of a new intervention review and meta-analysis, neither paracervical block with lidocaine nor conscious sedation significantly reduced overall pain scores for tubal sterilization with hysteroscopy.
Read More
Most Progestin-Only Contraceptives Do Not Increase Venous Thromboembolism Risk
September 12th 2012Compared with women who do not use hormonal contraception, most women who take progestin-only contraception are not at increased risk for venous thromboembolism, according to the results of a new meta-analysis.
Read More
Combined Hormonal Birth Control: Fear-Promoting Headlines Just Hype
July 9th 2012In the largest study of its kind, researchers found increased risk for myocardial infarction and thrombotic stroke in women using combined estrogen-progestin contraceptives. However, news headlines tend to overstate the risk, and patients may have new concerns about the safety of their hormonal contraceptive.
Read More
IUDs Are Effective Emergency Contraception
May 18th 2012Typically used for long-term contraception, the intrauterine device (IUD) is also an effective emergency contraceptive if implanted after unprotected sex. Two IUDs, which are T-shaped pieces of plastic, are available in the United States.
Read More
ACOG: Providers Underestimate Pain Intensity During IUD Insertion
May 8th 2012Providers underestimate the intensity of patients’ pain during IUD insertion, and often misidentify the moment at which maximum pain occurs, according to a randomized trial of 200 women. Midlevel providers are slightly better at estimating pain intensity.
Read More
Ulipristal is Safe and Effective for Uterine Fibroids
February 10th 2012Ulipristal is a safe and effective option for women with uterine fibroids, according to two new studies published in the New England Journal of Medicine. In both studies, the oral selective progesterone receptor modulator was well-tolerated, rapidly reduced excessive bleeding, and decreased the size of uterine fibroids.
Read More
The Utility of Magnetic Resonance Imaging (MRI) and How It Is Used to Diagnose Uterine Fibroids
December 7th 2011William Parker, MD discusses the use of MRI in diagnosing and managing uterine fibroids. Dr. Parker's upcoming Clinical Opinion article, “The utility of MRI for the surgical treatment of women with uterine fibroid tumors”, will be published in the American Journal of Obstetrics and Gynecology in 2012.
Read More
Genital Wart Management: A Partnership Between Physician and Patient
With its implications of sexual transmission and potential cervical cancer, a diagnosis of genital warts can be emotionally distressing to patients. Because no single treatment serves every patient, the best approach to selecting a therapeutic option considers the extent of the disease, wart location, and the patient's individual needs.
Read More